Loading…

Protocol - Anxiety Disorders Symptoms - Adult

Add to Toolkit

Protocol Name from Source:

Symptom Check List 90 (SCL-90)

Availability:

Publicly available

Description:

This protocol includes the anxiety subscale of the Symptom Check List 90 (SCL-90). The anxiety subscale of the SCL-90 includes self-administered questions for adults that cover primary symptom dimensions and provide an overview of the respondent’s symptoms and their intensity at a specific point in time. Each item is scored on a scale of 0 to 4 (with 0 = not at all, 1 = a little bit, 2 = moderately, 3 = quite a bit, and 4 = extremely), asking respondents which number best describes how much that problem has bothered them in the last 4 weeks.

Protocol:

Symptom Assessment from the Symptom Check List 90

The Symptom Check List 90 is published and distributed exclusively by NCS Pearson, Inc., and can be obtained through:

Pearson
Attn: Customer Service
P.O. Box 599700
San Antonio, TX 78259
Telephone: 800.627.7271
Email: clinicalcustomersupport@pearson.com

Personnel and Training Required

None

Equipment Needs

None

Requirements

Requirement CategoryRequired
Average time of greater than 15 minutes in an unaffected individualNo
Major equipmentNo
Specialized requirements for biospecimen collectionNo
Specialized trainingNo

Mode of Administration

Self-administered

Life Stage:

Adult, Senior, Pregnancy

Specific Instructions:

The Symptom Checklist 90 (SCL-90) is a proprietary, fee-based instrument that is available from Pearson Education, Inc.

Research Domain Information

Release Date:

November 28, 2017

Definition

A questionnaire to assess anxiety disorders, which include a number of different conditions such as panic disorder, generalized anxiety disorder, social phobia, specific phobia, agoraphobia, obsessive-compulsive disorder, and posttraumatic stress disorder (APA, 2000).

Purpose

This measure is used to screen an individual for the presence of anxiety disorders and to assess the severity of underlying symptoms. Anxiety disorders are one of the most prevalent psychiatric conditions occurring in about 18 percent of the population (Kessler et al., 2005). Anxiety disorders may be influenced by genetics and environmental factors and commonly occur with other physical conditions, such as cardiovascular, respiratory, and gastrointestinal disease, as well as with other mental illnesses such as depression and substance abuse disorders (APA, 2000). Furthermore, a significant proportion of pediatric psychiatric patients have anxiety disorders.

Selection Rationale

The Symptom Check List 90 (SCL-90) was selected to provide a quantitative measure of anxiety symptoms rather than simply categorical diagnoses. SCL-90 was vetted against several other dimensional measures of anxiety disorders and ultimately selected because it is easily administered as a self-reported instrument, takes less than 15 minutes, and captures general symptoms of anxiety.

Language

Arabic, Dutch, English, French, Mandarin Chinese, Spanish

Standards

StandardNameIDSource

Process and Review

[link[phenx.org/node/103|Expert Review Panel 4]] (ERP 4) reviewed the measures in the Neurology, Psychiatric, and Psychosocial domains.

Guidance from ERP 4 includes the following:

  • New Measure

Source

Derogatis, L. R, Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale-Preliminary report. Psychopharmacology Bulletin, 9(1), 13-28.

The Symptom Check List 90 (SCL-90) is published and distributed exclusively by NCS Pearson, Inc., and can be obtained through:

Pearson
Attn: Customer Service
P.O. Box 599700
San Antonio, TX 78259
Telephone: 800.627.7271
Email: clinicalcustomersupport@pearson.com

General References

American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.

Dai, Y., Li, X., Zhang, X., Wang, S., Sang, J., Tian, X., & Cao, H. (2016). Prevalence and predisposing factors for depressive status in Chinese patients with obstructive sleep apnoea: A large-sample survey. PLoS ONE, 11(3), e0149939.

Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62(6), 617-627.

Loesch, D. Z., Bui, M, Q., Hammersley, E., Schneider, A., Storey, E., Stimpson, P., Burgess, T., Francis, D., Slater, H., Tassone, F., Hagerman, R. J., & Hessl, D. (2015). Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clinical Genetics, 87(2), 173-178.

Protocol ID:

121803

Variables:

Export Variables
Variable NameVariable IDVariable DescriptionVersiondbGaP Mapping